PGM is pleased to announce the addition of Kien Nguyen to the Progenerative team.  Kien played a key role in the early concept development of Regenn™ Therapy while at Kinetic Concepts, Inc., and brings valuable technology and market experience to the PGM team.  Over the past 20 years, Kien has worked on the development and commercialization of many novel medical devices for tissue regeneration, surgical hemostasis, knee reconstructive surgery, and obstructive sleep apnea.

I’m excited to join the team and play a role in moving the company forward – Kien Nguyen, Chief Commercialization Officer

At PGM Kien will lead or co-lead the Company’s fund raising efforts, identify and develop strategic partnering opportunities, and work closely with our Board, clinical and reimbursement advisors to establish the patient and health economic benefits of Regenn™  Therapy.